Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ciprandi

Showing results (191-200 of 403) with videos related to

Pageof 41
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 31, 1997
Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expressionG Ciprandi, C Pronzato, V Ricca, et al.
Allergy|September 23, 1997
Specific conjunctival challenge in polysensitized subjectsG Ciprandi, A Catrullo, A Ballestrero, et al.
International Archives of Allergy and Immunology|March 3, 1998
Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallengeG Ciprandi, V Ricca, M Landi, et al.
Acta Endocrinologica|November 1, 1985
Autologous mixed lymphocyte reaction in Graves' disease: relationship to clinical statusM Bagnasco, G Ciprandi, A Orlandini, et al.
Allergologia Et Immunopathologia|July 1, 1987
Terfenadine (single or associated) treatment of adverse reactions to foodsG Ciprandi, A Scordamaglia, S Ruffoni, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2010
Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitisG Ciprandi, M De Amici, M A Tosca, et al.
Minerva Chirurgica|October 1, 2014
Evaluation of the effectiveness of a polyhexanide and propyl betaine-based gel in the treatment of chronic woundsC M Durante, A Greco, O Sidoli, et al.
Journal of Biological Regulators and Homeostatic Agents|March 21, 2019
Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disordersG F Cupido, M Gelardi, I La Mantia, et al.
Journal of Investigational Allergology & Clinical Immunology|June 16, 2012
Serum IL-9 levels in patients with spontaneous urticaria: a preliminary studyG Ciprandi, M De Amici, S Legoratto, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 19, 2005
The safety of sublingual-swallow immunotherapy: an analysis of published studiesG B Gidaro, F Marcucci, L Sensi, et al.
Pageof 41

Showing results (191-200 of 403) with videos related to

Sort By:
Pageof 41
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 31, 1997
Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expressionG Ciprandi, C Pronzato, V Ricca, et al.
Allergy|September 23, 1997
Specific conjunctival challenge in polysensitized subjectsG Ciprandi, A Catrullo, A Ballestrero, et al.
International Archives of Allergy and Immunology|March 3, 1998
Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallengeG Ciprandi, V Ricca, M Landi, et al.
Acta Endocrinologica|November 1, 1985
Autologous mixed lymphocyte reaction in Graves' disease: relationship to clinical statusM Bagnasco, G Ciprandi, A Orlandini, et al.
Allergologia Et Immunopathologia|July 1, 1987
Terfenadine (single or associated) treatment of adverse reactions to foodsG Ciprandi, A Scordamaglia, S Ruffoni, et al.
International Journal of Immunopathology and Pharmacology|January 16, 2010
Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitisG Ciprandi, M De Amici, M A Tosca, et al.
Minerva Chirurgica|October 1, 2014
Evaluation of the effectiveness of a polyhexanide and propyl betaine-based gel in the treatment of chronic woundsC M Durante, A Greco, O Sidoli, et al.
Journal of Biological Regulators and Homeostatic Agents|March 21, 2019
Broser® (bromelain, escin and selenium), oral nutraceutical, monotherapy in patients with inflammatory otorhinolaryngological disordersG F Cupido, M Gelardi, I La Mantia, et al.
Journal of Investigational Allergology & Clinical Immunology|June 16, 2012
Serum IL-9 levels in patients with spontaneous urticaria: a preliminary studyG Ciprandi, M De Amici, S Legoratto, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 19, 2005
The safety of sublingual-swallow immunotherapy: an analysis of published studiesG B Gidaro, F Marcucci, L Sensi, et al.
Pageof 41